All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ 36-month results from first-in-human study with shape-changing IOL
➤ New data for recently approved EDOF IOL
➤ Company completes first-in-human robotic cataract surgery
➤ Phase 2 study approved for secondary IOL intended for low-vision patients
➤ Investigational device measures real-time intraoperative aqueous outflow
➤ FDA expands dosing on label for faricimab
➤ Company news
➤ ASCRS news and events
➤ Keep up with ASCRS Annual Meeting coverage with EyeWorld Onsite
➤ Positive topline results from Phase 3 trial for TED drug with new delivery method
➤ FDA expands dosing interval for wet AMD, DME treatment
➤ IDE granted to noninvasive bioelectric stimulation therapy for dry AMD
➤ First patients dosed in Phase 3 corneal cell therapy
➤ TED investigational treatment fails to meet primary endpoint
➤ OTC eye drop recall after FDA enforcement report cites sterility concerns
➤ ASCRS news and events
Oral sedation for cataract surgery has been used in some capacity for at least the last 20 years in the U.S., and discussion has begun on whether oral sedation options could become the primary care model within ASCs and hospital settings. Three cataract surgeons weighed in on the topic.
Two physicians shared their thoughts on the various ways to manage astigmatism, what levels to treat, and how they decide the best option for each patient.
The McGee Eye Institute ophthalmology residents reviewed “Use of intracameral antibiotics prophylaxis in patients with posterior capsular rupture during cataract surgery: a systematic review and meta-analysis” from the Journal of Cataract & Refractive Surgery.
Detecting irregular astigmatism early has taken on greater importance, particularly in the context of cataract surgery planning and patient satisfaction. Understanding how these findings are detected and why they matter clinically is becoming an essential part of preoperative evaluation, according to sources who weighed in on the topic.
➤ 24-month pivotal data support efficacy of laser treatment for glaucoma
➤ Low-dose atropine drop meets primary, secondary endpoints in new data analysis
➤ Phase 2 topline data for modifier gene therapy for geographic atrophy
➤ Phase 2 data from study evaluating neuropathic corneal pain shows quality of life improvement
➤ New shelf-stable corneal endothelial cell therapy program begins
➤ ASCRS news and events
Having varying degrees of zonulopathy can make a case more challenging. Two surgeons discussed what they look for to determine if a patient has some form of zonulopathy, the best lenses and tools to use in these cases, and other important approaches to proceeding with surgery.
➤ FDA approves new EDOF with limited dysphotopsias
➤ Phase 1/2 12-month data for IOL-based drug delivery system
➤ Topline results from Phase 2a wet AMD study
➤ FDA grants Breakthrough Device Designation to brain implant technology
➤ FDA allows Phase 1/2 trial to begin for investigational cell therapy for familial drusen
➤ ASCRS news and events
➤ First patient treated with novel crosslinking approach for refractive error
➤ Multisociety working group established to set guidelines for modern IOL classification
➤ FDA reduces clinical trial requirement for new drugs to one pivotal trial
➤ ASCRS news and events
